Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1948 1
1949 1
1950 2
1952 1
1957 1
1958 3
1962 1
1963 1
1964 2
1965 1
1968 3
1969 2
1970 1
1971 8
1972 3
1973 3
1974 7
1975 2
1976 2
1977 8
1978 2
1979 1
1980 1
1981 5
1982 2
1983 3
1984 4
1985 5
1986 5
1987 11
1988 15
1989 12
1990 16
1991 18
1992 20
1993 20
1994 22
1995 41
1996 34
1997 49
1998 47
1999 50
2000 72
2001 91
2002 121
2003 142
2004 189
2005 213
2006 281
2007 342
2008 415
2009 441
2010 536
2011 621
2012 699
2013 777
2014 786
2015 904
2016 787
2017 900
2018 830
2019 867
2020 956
2021 1055
2022 692
Text availability
Article attribute
Article type
Publication date

Search Results

11,638 results
Results by year
Filters applied: . Clear all
Page 1
Induction and Maintenance Treatment of Lupus Nephritis: A Comprehensive Review of Meta-Analyses.
Shin JI, Li H, Park S, Yang JW, Lee KH, Jo Y, Park S, Oh J, Kim H, An HJ, Jeong G, Jung H, Lee HJ, Kim JS, Nam SW, Koyanagi A, Jacob L, Hwang J, Yon DK, Lee SW, Tizaoui K, Kronbichler A, Kim JH, Smith L. Shin JI, et al. Among authors: lee hj. J Clin Med. 2022 Jan 11;11(2):343. doi: 10.3390/jcm11020343. J Clin Med. 2022. PMID: 35054037 Free PMC article. Review.
Response-adapted anti-PD-1-based salvage therapy for Hodgkin lymphoma with nivolumab alone or in combination with ICE.
Mei MG, Lee HJ, Palmer JM, Chen R, Tsai NC, Chen L, McBride K, Smith DL, Melgar I, Song JY, Bonjoc KJ, Armenian S, Nwangwu M, Lee PP, Zain J, Nikolaenko L, Popplewell L, Nademanee A, Chaudhry A, Rosen S, Kwak L, Forman SJ, Herrera AF. Mei MG, et al. Among authors: lee hj. Blood. 2022 Jun 23;139(25):3605-3616. doi: 10.1182/blood.2022015423. Blood. 2022. PMID: 35316328 Clinical Trial.
A diverse fibroblastic stromal cell landscape in the spleen directs tissue homeostasis and immunity.
Alexandre YO, Schienstock D, Lee HJ, Gandolfo LC, Williams CG, Devi S, Pal B, Groom JR, Cao W, Christo SN, Gordon CL, Starkey G, D'Costa R, Mackay LK, Haque A, Ludewig B, Belz GT, Mueller SN. Alexandre YO, et al. Among authors: lee hj. Sci Immunol. 2022 Jan 7;7(67):eabj0641. doi: 10.1126/sciimmunol.abj0641. Epub 2022 Jan 7. Sci Immunol. 2022. PMID: 34995096
Ibrutinib-rituximab followed by R-HCVAD as frontline treatment for young patients (≤65 years) with mantle cell lymphoma (WINDOW-1): a single-arm, phase 2 trial.
Wang ML, Jain P, Zhao S, Lee HJ, Nastoupil L, Fayad L, Ok CY, Kanagal-Shamanna R, Hill HA, Yao Y, Hagemeister FB, Westin JR, Fowler N, Samaniego F, Steiner R, Nair R, Iyer SP, Navsaria L, Badillo M; Mantle Cell Research Group, Feng L, Xuelin H, Nogueras Gonzalez GM, Xu G, Wagner-Bartak N, Thirumurthi S, Santos D, Tang G, Lin P, Wang SA, Jorgensen J, Yin CC, Li S, Patel KP, Vega F, Medeiros LJ, Flowers CR, Wang L. Wang ML, et al. Among authors: lee hj. Lancet Oncol. 2022 Mar;23(3):406-415. doi: 10.1016/S1470-2045(21)00638-0. Epub 2022 Jan 21. Lancet Oncol. 2022. PMID: 35074072 Clinical Trial.
11,638 results
You have reached the last available page of results. Please see the User Guide for more information.